
Vista Pharmaceuticals Ltd Falls to 52-Week Low of Rs 5.5 as Sell-Off Deepens
2026-09-08 14:45:14For the second consecutive session, Vista Pharmaceuticals Ltd has seen its share price decline, hitting a fresh 52-week low of Rs 5.5 on 8 Sep 2026. This latest drop extends the stock’s downward trajectory, which has now resulted in a 5.41% loss over just two days, underscoring persistent selling pressure amid broader market weakness.
Read full news article
Vista Pharmaceuticals Ltd is Rated Strong Sell
2026-08-27 10:10:22Vista Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 18 July 2024. However, the analysis and financial metrics discussed below reflect the company’s current position as of 27 August 2026, providing investors with the latest insights into the stock’s performance and outlook.
Read full news article
Vista Pharmaceuticals Ltd is Rated Strong Sell
2026-08-12 10:11:22Vista Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 18 July 2024, but the analysis below reflects the stock’s current position as of 12 August 2026, incorporating the latest fundamentals, returns, and financial metrics available today.
Read full news article
Vista Pharmaceuticals Ltd is Rated Strong Sell
2026-07-29 10:10:57Vista Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 18 Jul 2024. However, the analysis and financial metrics presented here reflect the stock's current position as of 29 July 2026, providing investors with an up-to-date view of the company’s performance and outlook.
Read full news article
Vista Pharmaceuticals Ltd is Rated Strong Sell
2026-07-15 10:10:33Vista Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 18 July 2024. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 15 July 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and overall outlook.
Read full news article
Vista Pharmaceuticals Ltd is Rated Strong Sell
2026-07-01 10:10:22Vista Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 18 Jul 2024, reflecting a significant reassessment of the stock’s outlook. However, the analysis and financial metrics presented here are based on the company’s current position as of 01 July 2026, providing investors with the latest insights into its performance and prospects.
Read full news article
Vista Pharmaceuticals Ltd is Rated Strong Sell
2026-06-18 10:10:34Vista Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 18 Jul 2024. However, the analysis and financial metrics presented here reflect the company’s current position as of 18 June 2026, providing investors with the latest insights into its performance and outlook.
Read full news articleResults For The Quarter Ended 30.06.2026
14-Aug-2026 | Source : BSEResults for the quarter ended 30.06.2026
Board Meeting Outcome for Results For The Quarter Ended 30.06.2026
14-Aug-2026 | Source : BSEResults for the quarter ended 30.06.2026
Board Meeting Intimation for Approval Of Un Audited Financials Results For The Quarter Ended 30.06.2026
13-Aug-2026 | Source : BSEVista Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 inter alia to consider and approve 1. Unaudited financial results for the quarter ended 30.06.2026
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available






